By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > News > Medifast: Strong Balance Sheet, But I Lack Conviction In The Turnaround (NYSE:MED)
News

Medifast: Strong Balance Sheet, But I Lack Conviction In The Turnaround (NYSE:MED)

News Room
Last updated: 2025/01/20 at 5:30 PM
By News Room
Share
2 Min Read
SHARE

This article was written by

I am a software developer by trade who focuses on finding value in the market wherever it may lie. I’m looking mainly in small caps for opportunities that provide asymmetric upside. I’m also interested in generating income through my investments, which leads me to look at high dividend yields that are sustainable. Things I look for in a business include insider buying and high insider ownership, a long history of free cash flow growth, substantial catalysts that can lead to a turnaround or a sufficiently high book value. I am open to plays such as high yield debt and selling puts, but am not interested in taking short positions. My biggest investment influences include Warren Buffett and Peter Lynch. My preferred holding period is forever. I am comfortable with matching market returns during bull runs and generating superior returns as the market falls. I have a Bachelor of Science with a major in Economics and Finance.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of MED either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

News Room January 20, 2025 January 20, 2025
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
In 2026, we’re channeling Powell to reach all of our goals.

Watch full video on YouTube

Why It Feels Like Every Movie Is Just Another Sequel

Watch full video on YouTube

US government releases millions of Jeffrey Epstein documents

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

Nvidia and AMD unveil new chips at CES, businesses are optimistic despite inflation

Watch full video on YouTube

Meta’s $2 Billion Bet To Win Over Enterprise Customers

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

News

US government releases millions of Jeffrey Epstein documents

By News Room
News

Tesla lurches into the Musk robotics era

By News Room
News

Donald Trump’s ‘beautiful armada’ underlines US threat to Iran

By News Room
News

Keir Starmer meets Xi Jinping in bid to revive strained UK-China ties

By News Room
News

Meta Stock: Shock And Awe (Rating Downgrade) (NASDAQ:META)

By News Room
News

Qorvo, Inc. (QRVO) Q3 2026 Earnings Call Transcript

By News Room
News

Anthropic doubles VC fundraising to $20bn on surging investor demand

By News Room
News

EU and India seal trade deal to slash €4bn of tariffs on bloc’s exports

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?